196 related articles for article (PubMed ID: 20052460)
1. Scutellarin exerts its anti-hypertrophic effects via suppressing the Ca2+-mediated calcineurin and CaMKII signaling pathways.
Pan ZW; Zhang Y; Mei DH; Zhang R; Wang JH; Zhang XY; Xu CQ; Lu YJ; Yang BF
Naunyn Schmiedebergs Arch Pharmacol; 2010 Feb; 381(2):137-45. PubMed ID: 20052460
[TBL] [Abstract][Full Text] [Related]
2. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
3. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
4. Scutellarin-induced endothelium-independent relaxation in rat aorta.
Pan Z; Feng T; Shan L; Cai B; Chu W; Niu H; Lu Y; Yang B
Phytother Res; 2008 Nov; 22(11):1428-33. PubMed ID: 18972583
[TBL] [Abstract][Full Text] [Related]
5. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
7. Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy.
Zhu W; Zou Y; Shiojima I; Kudoh S; Aikawa R; Hayashi D; Mizukami M; Toko H; Shibasaki F; Yazaki Y; Nagai R; Komuro I
J Biol Chem; 2000 May; 275(20):15239-45. PubMed ID: 10809760
[TBL] [Abstract][Full Text] [Related]
8. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
[TBL] [Abstract][Full Text] [Related]
9. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of
Zhu J; Chen L; Qi Y; Feng J; Zhu L; Bai Y; Wu H
Mol Vis; 2018; 24():315-325. PubMed ID: 29769797
[TBL] [Abstract][Full Text] [Related]
11. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway.
Li CY; Wang Q; Wang X; Li G; Shen S; Wei X
Eur J Pharmacol; 2019 Sep; 858():172463. PubMed ID: 31211986
[TBL] [Abstract][Full Text] [Related]
12. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
13. Scutellarin ameliorates cartilage degeneration in osteoarthritis by inhibiting the Wnt/β-catenin and MAPK signaling pathways.
Liu F; Li L; Lu W; Ding Z; Huang W; Li YT; Cheng C; Shan WS; Xu J; He W; Zhanghui ; Yin Z
Int Immunopharmacol; 2020 Jan; 78():105954. PubMed ID: 31757676
[TBL] [Abstract][Full Text] [Related]
14. The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy.
Chen CH; Lin JW; Huang CY; Yeh YL; Shen CY; Badrealam KF; Ho TJ; Padma VV; Kuo WW; Huang CY
J Cell Physiol; 2020 Apr; 235(4):3539-3547. PubMed ID: 31584202
[TBL] [Abstract][Full Text] [Related]
15. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
16. The role of Ca2+/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy.
Wang GJ; Wang HX; Yao YS; Guo LY; Liu P
Braz J Med Biol Res; 2012 Nov; 45(11):1045-51. PubMed ID: 22832601
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation.
Wang S; Wang H; Guo H; Kang L; Gao X; Hu L
Neuroscience; 2011 Jun; 185():150-60. PubMed ID: 21524691
[TBL] [Abstract][Full Text] [Related]
18. Multiprotein bridging factor 1 cooperates with c-Jun and is necessary for cardiac hypertrophy in vitro.
Busk PK; Wulf-Andersen L; Strøm CC; Enevoldsen M; Thirstrup K; Haunsø S; Sheikh SP
Exp Cell Res; 2003 May; 286(1):102-14. PubMed ID: 12729799
[TBL] [Abstract][Full Text] [Related]
19. Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
Wang WW; Lu L; Bao TH; Zhang HM; Yuan J; Miao W; Wang SF; Xiao ZC
J Mol Neurosci; 2016 Feb; 58(2):210-20. PubMed ID: 26514969
[TBL] [Abstract][Full Text] [Related]
20. Scutellarin suppresses cartilage destruction in osteoarthritis mouse model by inhibiting the NF-κB and PI3K/AKT signaling pathways.
Wang W; Li J; Li F; Peng J; Xu M; Shangguan Y; Li Y; Zhao Y; Qiu C; Qu R; Li W; Zhang C; Zhang T
Int Immunopharmacol; 2019 Dec; 77():105928. PubMed ID: 31711940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
